174 related articles for article (PubMed ID: 31300540)
1. Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Washino S; Rider LC; Romero L; Jillson LK; Affandi T; Ohm AM; Lam ET; Reyland ME; Costello JC; Cramer SD
Mol Cancer Res; 2019 Oct; 17(10):1985-1998. PubMed ID: 31300540
[TBL] [Abstract][Full Text] [Related]
2.
Jillson LK; Rider LC; Rodrigues LU; Romero L; Karimpour-Fard A; Nieto C; Gillette C; Torkko K; Danis E; Smith EE; Nolley R; Peehl DM; Lucia MS; Costello JC; Cramer SD
Mol Cancer Res; 2021 Jul; 19(7):1123-1136. PubMed ID: 33846123
[TBL] [Abstract][Full Text] [Related]
3. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
[TBL] [Abstract][Full Text] [Related]
4. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.
Rodrigues LU; Rider L; Nieto C; Romero L; Karimpour-Fard A; Loda M; Lucia MS; Wu M; Shi L; Cimic A; Sirintrapun SJ; Nolley R; Pac C; Chen H; Peehl DM; Xu J; Liu W; Costello JC; Cramer SD
Cancer Res; 2015 Mar; 75(6):1021-34. PubMed ID: 25770290
[TBL] [Abstract][Full Text] [Related]
5. A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.
Alagpulinsa DA; Ayyadevara S; Yaccoby S; Shmookler Reis RJ
Mol Cancer Ther; 2016 Feb; 15(2):241-50. PubMed ID: 26719576
[TBL] [Abstract][Full Text] [Related]
6. CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.
Shenoy TR; Boysen G; Wang MY; Xu QZ; Guo W; Koh FM; Wang C; Zhang LZ; Wang Y; Gil V; Aziz S; Christova R; Rodrigues DN; Crespo M; Rescigno P; Tunariu N; Riisnaes R; Zafeiriou Z; Flohr P; Yuan W; Knight E; Swain A; Ramalho-Santos M; Xu DY; de Bono J; Wu H
Ann Oncol; 2017 Jul; 28(7):1495-1507. PubMed ID: 28383660
[TBL] [Abstract][Full Text] [Related]
7. CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
Zhu Y; Wen J; Huang G; Mittlesteadt J; Wen X; Lu X
Prostate; 2021 Jan; 81(1):81-88. PubMed ID: 33022763
[TBL] [Abstract][Full Text] [Related]
8. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.
Chao OS; Goodman OB
Mol Cancer Res; 2014 Dec; 12(12):1755-66. PubMed ID: 25127709
[TBL] [Abstract][Full Text] [Related]
9. Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
Kari V; Mansour WY; Raul SK; Baumgart SJ; Mund A; Grade M; Sirma H; Simon R; Will H; Dobbelstein M; Dikomey E; Johnsen SA
EMBO Rep; 2016 Nov; 17(11):1609-1623. PubMed ID: 27596623
[TBL] [Abstract][Full Text] [Related]
10. O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.
Chen SH; Huang WT; Kao WC; Hsiao SY; Pan HY; Fang CW; Shiue YL; Chou CL; Li CF
J Biomed Sci; 2021 Jan; 28(1):2. PubMed ID: 33397362
[TBL] [Abstract][Full Text] [Related]
11. Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.
Ormond DR; Kleinschmidt-DeMasters BK; Cavalcante D; Smith EE; Cramer SD; Lucia MS
J Neurooncol; 2019 Apr; 142(2):319-325. PubMed ID: 30656528
[TBL] [Abstract][Full Text] [Related]
12. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.
Mani C; Jonnalagadda S; Lingareddy J; Awasthi S; Gmeiner WH; Palle K
Breast Cancer Res; 2019 Sep; 21(1):104. PubMed ID: 31492187
[TBL] [Abstract][Full Text] [Related]
13. MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression.
Huang Z; Tang B; Yang Y; Yang Z; Shi L; Bai Y; Yan B; Karnes RJ; Zhang J; Jimenez R; Wang L; Wei Q; Yang J; Xu W; Jia Z; Huang H
Cancer Res; 2021 Sep; 81(17):4471-4484. PubMed ID: 34158377
[TBL] [Abstract][Full Text] [Related]
14.
Bayne RS; Puckett S; Rodrigues LU; Cramer SD; Lee J; Furdui CM; Chou JW; Miller LD; Ornelles DA; Lyles DS
Mol Ther Oncolytics; 2020 Jun; 17():496-507. PubMed ID: 32529027
[TBL] [Abstract][Full Text] [Related]
15. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
16. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.
Dai CH; Chen P; Li J; Lan T; Chen YC; Qian H; Chen K; Li MY
Oncotarget; 2016 Oct; 7(40):65157-65170. PubMed ID: 27533083
[TBL] [Abstract][Full Text] [Related]
17. Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus.
Zhou J; Li J; Serafim RB; Ketchum S; Ferreira CG; Liu JC; Coe KA; Price BD; Yusufzai T
Nucleic Acids Res; 2018 May; 46(8):3891-3905. PubMed ID: 29529298
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer Patients with Late Radiation Toxicity Exhibit Reduced Expression of Genes Involved in DNA Double-Strand Break Repair and Homologous Recombination.
van Oorschot B; Uitterhoeve L; Oomen I; Ten Cate R; Medema JP; Vrieling H; Stalpers LJ; Moerland PD; Franken NA
Cancer Res; 2017 Mar; 77(6):1485-1491. PubMed ID: 28108515
[TBL] [Abstract][Full Text] [Related]
19. Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells.
Wang H; Zhang S; Song L; Qu M; Zou Z
Oncogene; 2020 Apr; 39(14):2905-2920. PubMed ID: 32029902
[TBL] [Abstract][Full Text] [Related]
20. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
